A Randomized, blinded assessor study to Evaluate the efFIcacy and safety of etanercept 50 mg once weekly plus as Needed topical agent vs. Etanercept 50 mg twice weekly in patients with moderate to severe plaque psoriasis (REFINE)

BACKGROUND: Topical corticosteroids are used with systemic therapies for treatment of plaque psoriasis, but data from randomized clinical trials to document efficacy of combination therapy are lacking. OBJECTIVE: To evaluate efficacy and safety of adding topical corticosteroid therapy from the time...

Descripción completa

Detalles Bibliográficos
Autores principales: Papp, KA, Barber, K, Bissonnette, R, Bourcier, M, Lynde, CW, Poulin, Y, Shelton, J, Toole, J, Vieira, A, Poulin-Costello, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340046/
https://www.ncbi.nlm.nih.gov/pubmed/24980988
http://dx.doi.org/10.1111/jdv.12555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340046/
https://www.ncbi.nlm.nih.gov/pubmed/24980988
http://dx.doi.org/10.1111/jdv.12555

Ejemplares similares